This ‘poop pill’ could be a breakthrough for cancer that only has a 10% survival rate
They’re taking the plunge. A small number of Canadian cancer patients are testing a pill that contains healthy bacteria from ...
F.D.A. Nominee to Face Grilling Over Cutbacks and Policy Shifts
Dr. Marty Makary will testify before the Senate health committee on Thursday. Lawmakers may press him over staff reductions ...
Medscape12d
Novel Blood Test Enables Early Pancreatic Cancer Detection
A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...
GlobalData on MSN4d
Tumour-on-chip model could help discover pancreatic cancer therapies
A team of German scientists and biotech company Dynamic42 have jointly developed a ‘tumour-on-chip’ model of pancreatic ...
ImmunityBio Shares Up, FDA Gives RMAT Designation for Treatment of Lymphopenia in Cancer Patients
ImmunityBio shares advanced 17% to $3.34 after the company said the Food and Drug Administration awarded a regenerative medicine advanced therapy designation for Anktiva and CAR-NK for the reversal of ...
Tango Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Highlights
TNG462 granted Orphan Drug Designation for treatment of pancreatic cancer –– Investigational New Drug (IND) application for TNG456, a ...
Can-Fite Innovative Publication: Namodenoson in Liver Cancer Treatment Alongside with Cardiac, Liver, and Neurological Benefits
Unlike chemotherapy with its known toxicity towards normal body systems, Namodenoson provides protective effectsRamat Gan, Israel, March 03, ...